Sage Therapeutics, Inc. (SAGE): Price and Financial Metrics

Sage Therapeutics, Inc. (SAGE)

Today's Latest Price: $71.84 USD

1.43 (-1.95%)

Updated Jan 22 4:00pm

Add SAGE to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 322 in Biotech

See all "A" rated Strong Buy stocks

SAGE Stock Summary

  • Sage Therapeutics Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than merely 7.41% of US listed stocks.
  • With a price/sales ratio of 749.21, Sage Therapeutics Inc has a higher such ratio than 99.6% of stocks in our set.
  • As for revenue growth, note that SAGE's revenue has grown -94.24% over the past 12 months; that beats the revenue growth of merely 0.65% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to Sage Therapeutics Inc, a group of peers worth examining would be NLNK, PRTA, CVM, KDMN, and NYMX.
  • Visit SAGE's SEC page to see the company's official filings. To visit the company's web site, go to
SAGE Daily Price Range
SAGE 52-Week Price Range

SAGE Stock Price Chart More Charts

SAGE Price/Volume Stats

Current price $71.84 52-week high $193.56
Prev. close $73.27 52-week low $56.50
Day low $71.66 Volume 733,460
Day high $75.21 Avg. volume 872,971
50-day MA $99.66 Dividend yield N/A
200-day MA $147.84 Market Cap 3.72B

Sage Therapeutics, Inc. (SAGE) Company Bio

Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare central nervous system, or CNS, disorders. The company was founded in 2010 and is based in Cambridge, Massachusetts.

SAGE Latest News Stream

Event/Time News Detail
Loading, please wait...

SAGE Latest Social Stream

Loading social stream, please wait...

View Full SAGE Social Stream

SAGE Price Returns

1-mo -3.75%
3-mo -49.33%
6-mo -56.85%
1-year -47.67%
3-year 34.99%
5-year 87.82%
YTD -0.48%
2019 -24.64%
2018 -41.84%
2017 222.58%
2016 -12.42%
2015 59.29%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.5651 seconds.